Authors
Loading...
Research demonstrates PKM2's potential as a diagnostic biomarker in ovarian cancer, suggesting novel therapeutic approaches.
Borra et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: